expands its frontiers
2007, PerkinElmer India has consolidated its stand in India
and has ambitious plans on going forward
PerkinElmer India reported a turnover of Rs 140
crore for the year 2008-09. The company’s life sciences
business accounted for 27 percent of this amounting to Rs 37.80 crore.
A wholly-owned subsidiary of PerkinElmer, the company operates as
direct sales, service and marketing operation targeting
India’s thriving life science and analytical instrumentation
markets. Globally, the company reported revenue of approximately $2
billion in 2008, has around 8,500 employees serving customers in more
than 150 countries, and is a component of the S&P 500 index.
The company provides precision instrumentation, testing systems and
components, software and services for a wide range of scientific and
industrial laboratory applications. Its products are used in predictive
diagnostics, personalized medicine and environmental monitoring.
PerkinElmer India currently employs approximately 170 people in
Bangalore, Baroda, Chennai, Hyderabad, Kolkata, Mumbai, New Delhi,
Pune, Lucknow, Chandigarh and Thiruvananthapuram.
PerkinElmer’s cellular imaging and analysis product regime
includes high content screening systems and image-based analysis with
platforms like Operetta, live cell imaging systems and softwares like
Acapella, Volocity and Columbus. In analytical sciences
space, products range includes FTIR and FTNIR spectrometers,
UV/Vis and NIR spectrometers-Raman spectrometers and imaging systems,
elemental analysis (TEA) atomic absorption (AA) spectrometers, coupled
plasma (ICP) mass spectrometry (MS), gas chromatographs and MS¯liquid
chromatographs (LC, HRLC and UHPLC), microscopy and imaging
system-other hyphenated techniques, data systems and laboratory
information management (LIMS) validations.
PerkinElmer has a Biodiscovery division
which mainly caters to the drug discovery customers with specialized
tools for cell biology related research. It has a plethora of reagents,
consumables and instruments which facilitate detection analysis and
further screening and profiling of various classes of druggable targets
like esp. kinases and GPCR’s. The company has also
set up a state-of-the-art Center of Excellence at Mumbai.
In addition to this recently the company has announced its plans to
establish a biopharma Center of Excellence in Hyderabad. This center
which will open in October, 2009, will be the second high-tech facility
recently established by PerkinElmer in India. The Hyderabad facility
complements the recently-opened PerkinElmer EcoAnalytix Center of
Excellence facility in Mumbai, established in May 2008 and dedicated to
environmental health sciences. The new biopharma center will provide
regional PerkinElmer clients and partners in India with access to
established and emerging drug discovery and pharmaceutical quality
assurance and control applications and technologies, training
facilities and expertise.